Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France
NCT00812357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 579
Last updated 2011-12-29
Summary
Descriptive pharmacoepidemiological study on the use of Symbicort Turbuhaler in the treatment of asthma in France and impact of a new therapeutic strategy on the compliance and control of asthma
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Stephane SCHÜCK, MD, MSc · KAPPA SANTE - Paris - France
-
Michel AUBIER, MD, Professor · CHU Bichat - Service de pneumologie - Paris - France
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2011-03-31
- Completion
- 2011-08-31
Countries
- France
Study Locations
More Related Trials
-
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
NCT01232348 ·Status: COMPLETED
-
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255 ·Status: COMPLETED ·Phase: PHASE3
-
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00252863 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Symbicort on GR Localisation in Asthma
NCT00159263 ·Status: COMPLETED ·Phase: NA
-
Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
NCT00573222 ·Status: COMPLETED
-
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
NCT00785733 ·Status: COMPLETED
-
Study to Investigate the Efficacy of Symbicort® SMART.
NCT00839800 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg
NCT00242775 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART
NCT00503061 ·Status: COMPLETED
-
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
NCT02224157 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice
NCT00505388 ·Status: COMPLETED
-
STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
NCT00252824 ·Status: COMPLETED ·Phase: PHASE3
-
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
NCT00532922 ·Status: COMPLETED
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT00784953 ·Status: COMPLETED
-
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
NCT00782314 ·Status: COMPLETED
-
A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®
NCT00884689 ·Status: COMPLETED
-
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
NCT00238784 ·Status: COMPLETED ·Phase: PHASE3
-
Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)
NCT00937066 ·Status: COMPLETED
-
Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler
NCT00812682 ·Status: COMPLETED
-
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
NCT00523679 ·Status: COMPLETED
-
Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy
NCT01711840 ·Status: COMPLETED
-
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
NCT01360021 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort in Asthmatic Children - SEEDLING
NCT00651547 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Rapihaler Therapeutic Equivalence Study
NCT00536731 ·Status: COMPLETED ·Phase: PHASE3